587 related articles for article (PubMed ID: 15333579)
1. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
[TBL] [Abstract][Full Text] [Related]
2. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
[TBL] [Abstract][Full Text] [Related]
3. Α-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation.
Wang Y; Xia Z; Xu JR; Wang YX; Hou LN; Qiu Y; Chen HZ
Neuropharmacology; 2012 Feb; 62(2):871-81. PubMed ID: 21958557
[TBL] [Abstract][Full Text] [Related]
4. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.
Scherzer-Attali R; Farfara D; Cooper I; Levin A; Ben-Romano T; Trudler D; Vientrov M; Shaltiel-Karyo R; Shalev DE; Segev-Amzaleg N; Gazit E; Segal D; Frenkel D
Neurobiol Dis; 2012 Jun; 46(3):663-72. PubMed ID: 22449754
[TBL] [Abstract][Full Text] [Related]
5. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
[TBL] [Abstract][Full Text] [Related]
6. Silibinin: a novel inhibitor of Aβ aggregation.
Yin F; Liu J; Ji X; Wang Y; Zidichouski J; Zhang J
Neurochem Int; 2011 Feb; 58(3):399-403. PubMed ID: 21185897
[TBL] [Abstract][Full Text] [Related]
7. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
9. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
10. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
Barghorn S; Nimmrich V; Striebinger A; Krantz C; Keller P; Janson B; Bahr M; Schmidt M; Bitner RS; Harlan J; Barlow E; Ebert U; Hillen H
J Neurochem; 2005 Nov; 95(3):834-47. PubMed ID: 16135089
[TBL] [Abstract][Full Text] [Related]
11. The Osaka FAD mutation E22Δ leads to the formation of a previously unknown type of amyloid β fibrils and modulates Aβ neurotoxicity.
Ovchinnikova OY; Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
J Mol Biol; 2011 May; 408(4):780-91. PubMed ID: 21402079
[TBL] [Abstract][Full Text] [Related]
12. [Compensatory function of transthyretin in Alzheimer's disease].
Shwartsman AL; Sarantseva SV
Tsitologiia; 2011; 53(10):772-7. PubMed ID: 22232933
[TBL] [Abstract][Full Text] [Related]
13. Glypican-1 as an Abeta binding HSPG in the human brain: its localization in DIG domains and possible roles in the pathogenesis of Alzheimer's disease.
Watanabe N; Araki W; Chui DH; Makifuchi T; Ihara Y; Tabira T
FASEB J; 2004 Jun; 18(9):1013-5. PubMed ID: 15084524
[TBL] [Abstract][Full Text] [Related]
14. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
Tomiyama T
Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
[TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
[TBL] [Abstract][Full Text] [Related]
16. Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide.
Sponne I; Fifre A; Koziel V; Oster T; Olivier JL; Pillot T
FASEB J; 2004 May; 18(7):836-8. PubMed ID: 15001562
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
[TBL] [Abstract][Full Text] [Related]
18. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
[TBL] [Abstract][Full Text] [Related]
19. Curcuminoid binds to amyloid-β1-42 oligomer and fibril.
Yanagisawa D; Taguchi H; Yamamoto A; Shirai N; Hirao K; Tooyama I
J Alzheimers Dis; 2011; 24 Suppl 2():33-42. PubMed ID: 21335654
[TBL] [Abstract][Full Text] [Related]
20. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
